The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Recursion Pharmaceuticals, Inc. | CL A | 75629V104 | 39,392,876 | 3,951,141 | SH | SOLE | 3,951,141 | 0 | 0 | |||
Rocket Lab USA, Inc. | COM | 773122106 | 29,604,474 | 7,203,035 | SH | SOLE | 7,203,035 | 0 | 0 | |||
Rigetti Computing, Inc. | COMMON STOCK | 76655K103 | 2,446,550 | 1,599,052 | SH | SOLE | 1,599,052 | 0 | 0 |